올릭스

226950KOSDAQ자연과학 및 공학 연구개발업

52.4 / 100

Reference Date: 2026-07-24

Financial Score10.5 / 40

News Sentiment20.9 / 25

Momentum6.0 / 20

Disclosure15.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 17.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Olix is a biopharmaceutical company specializing in developing therapeutic drugs for difficult-to-treat diseases using RNA interference (RNAi) platform technology. The company leverages its proprietary 'self-delivering asymmetric siRNA (cp-asiRNA)' technology to create drug candidates targeting metabolic diseases, obesity, and cardiovascular conditions. Through technology licensing agreements with global and domestic pharmaceutical companies, including a significant deal with Eli Lilly, Olix has established a strong market presence and revenue streams.

Number of Employees

76people

Average Salary

198.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

15.92Industry Average 2.520.0Point

6.3x industry avg (risky)

ROE

-18.68Industry Average -32.093.5Point

Below industry avg

Debt Ratio

15.97Industry Average 7.310.0Point

2.2x industry avg (risky)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲45.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼33.5% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -56.5% (improving, 3yr)

Detailed News Sentiment

8 totalPositive 7Neutral 0Negative 1Average Sentiment Score 83.8

Negative
코스피, 하루 만에 7000선 아래로…삼전 5%·하닉 8%대↓
코스피 하락과 함께 SK하이닉스 ADR이 하락하며 올릭스의 주가에도 부정적 영향 예상.
Positive
올릭스가 ‘시가총액 20조원 이상’을 목표로 제시한 이유는?
올릭스의 대규모 투자 계획 발표로 인해 신약 개발 성공 가능성 증가와 뷰티 시장 진출로 인한 긍정적 전망이 기대됩니다.
Positive
올릭스 신규 플랫폼 공개..."차세대 비만치료제 개발"
올릭스의 신규 플랫폼 OASIS-DUO 공개로 차세대 비만치료제 개발 가능성이 높아져 긍정적인 시장 반응 예상.

Detailed Momentum

52-week position5.0Point

52w mid range (42%)

Current 113,800Won52-week high 207,00052-week low 44,400

1-month return0.0Point

1m -17.77% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

12 totalPositive 3Neutral 9Negative 0

Neutral[기재정정]의결권대리행사권유참고서류2026-07-16
Neutral[기재정정]주주총회소집공고2026-07-16
Neutral주식매수선택권부여에관한신고2026-07-15
Neutral의결권대리행사권유참고서류2026-07-15
Neutral주주총회소집공고2026-07-15